AveXis
Why Robinhood?
You can watch AveXis and buy or sell other stocks, ETFs, and their options commission-free!About AVXS
AveXis , doing business as Novartis Gene Therapies, Inc., is a biotechnology company that specializes in the development and commercialization of gene therapies for patients and families affected by rare and life-threatening neurological genetic diseases. AveXis was acquired by Novartis on May 14, 2018.
AVXS Key Statistics
Stock Snapshot
The current AveXis(AVXS) stock price is $217.83, with a market capitalization of 8.02B. The stock trades at a price-to-earnings (P/E) ratio of -17.65.
During the trading day, AveXis(AVXS) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 608.43K.
The stock's 52-week range extends from a low of $65.54 to a high of $217.94.
The stock's 52-week range extends from a low of $65.54 to a high of $217.94.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.